Trial Profile
Dose Adaptation to Offset the Pharmacokinetic Interaction Between Ticagrelor and Ritonavir in Healthy Volunteers by Population-based PK Modeling (Simcyp)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ritonavir (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes; Cardiovascular disorders; Coronary artery disease; HIV infections; Peripheral arterial disorders; Stroke
- Focus Pharmacokinetics
- 06 Feb 2017 Status changed from active, no longer recruiting to completed.
- 09 May 2015 New trial record